We have developed a two-dose/single-sample protocol for the in vivo/in vitro rat hepatocyte unscheduled DNA synthesis (UDS) assay. In order to enhance the effectiveness of grain detection by image analysis we found minor technical modifications to be beneficial. These included the use of 3% acetic acid in ethanol (or 4% aqueous paraformaldehyde) for hepatocyte fixation and 0.5% aqueous eosin for staining. Also, there was no correlation between cell viability (measured using the trypan blue method) and UDS response and, therefore, we do not reject animals from data analysis unless hepatocyte viability falls below 50%. Furthermore, we suggest that cell attachment is a more reliable indicator of toxicity than of cell viability. Therefore, our range-finding test has been modified to incorporate an extra animal per group so that hepatocyte cultures can be evaluated. Comparisons of a two-dose/single-sample protocol with the currently accepted single-dose/multiple-sample protocol demonstrated that the former was an acceptable alternative, in that responses with standard positive controls are very similar with both protocols. Furthermore, the two-dose protocol has clear advantages in that it uses fewer animals, resources and time and has better statistical discriminatory power. As a move away from the use of arbitrary values for determining the performance and outcome of assays, we use criteria based on confidence limits placed on historical data ranges. Where necessary, statistical analyses of concurrent data is performed using rank transformation followed by parametric analysis of the ranks; this combines the generality of a non-parametric methodology with the power and versatility of parametric analyses.
Introduction
The purpose of this study was to develop the in vivo/in vitro rat hepatocyte unscheduled DNA synthesis (UDS) assay for routine genotoxicity testing. A major objective was to investigate the use of a two-dose/single-sample regime, thereby reducing the number of animals and other resources presently used per assay. Initially we followed current guidelines relating to the technical aspects of the in vivo/in vitro rat hepatocyte UDS assay (Kennelly et al., 1993) , but found it beneficial to modify some of the technical details, particularly to optimize for automated image analysis of the slides. In addition, we have adopted a statistical strategy which enables evaluation of results by applying confidence limits placed on historical data and using Dunnett's test (Dunnett, 1955; Bechhofer and Dunnett, 1988; Mahon et al., 1989) on rank-transformed concurrent data (Iman, 1974; Conover and Iman, 1981; Mitchell et al., 1994) , rather than using arbitrarily denned nett grain values for positive/negative classification.
Materials and methods

Animals
Sprague-Dawley (CD) male rats, 6-10 weeks old (250-300 g) at time of dosing, were obtained from Charles River (Manston, Kent, UK). Animals were grouped randomly and, within their groups, were housed together in polypropylene cages. Food and water were available ad libitum. Test chemicals and dosing A'^'-Dimethylhydrazine dihydrochloride (DMH), from Sigma, was dissolved in water and administered at 20 mg/kg; 2-acetylaminofluorene (2-AAF), from Sigma, was suspended in 1 % (w/v) (aqueous) methylcellulose and administered at 50 mg/kg; dimethylnitrosamine (DMN), from Sigma, was dissolved in water and administered at 2.5, 5.0 and 10.0 mg/kg. All compounds were dosed orally at a dose volume of 10 ml/kg. Two dosing regimes were used. With the single-dose method animals received the above doses for each compound once at the optimal time point (i.e. 2-4 h prior to sampling for DMH and DMN and 12-16 h prior to sampling for 2-AAF). DMN was administered at 10 mg/kg only by this method. With the multiple dosing method animals received the above doses for each compound twice, once at 12-16 h and once at 2-4 h prior to sampling. Hence, the total doses for DMH and 2-AAF were 40 and 100 mg/kg respectively and for DMN were 5.0, 10.0 and 20 mg/kg.
Fixatives and fixing regimes
With 25% (v/v) acetic acid/ethanol cells were fixed three times, each for 10 min, and then washed four times with purified water.
With 3% (v/v) acetic acid/ethanol cells were fixed for 5 and then 10 min followed by four washes with purified water.
With 4% (w/v) paraformaldehyde (PFA) 0.94 g NaH 2 PO 4 and 0.21 g NaOH were dissolved in 50 ml water, heated to 6O-80°C and 2 g PFA added, stirring continuously until dissolved. Once cooled to room temperature the pH was adjusted to 1.2-1 A with concentrated HC1. Cells were fixed for 10 min, followed by four washes with purified water.
Stains
Methyl green pyronin Y was prepared and used as described by Butterworth et al. (1987) .
Eosin yellowish (0.5 g) was dissolved in 100 ml water. Cells were stained for 10 s and then washed three times with purified water.
Test strategy DMH and 2-AAF are known to induce high levels of UDS in this assay and, therefore, for the purpose of comparing multiple and single dosing each was tested using only a single dose group of three animals. Furthermore, only 25 cells from each of two slides were scored per animal. DMN is also known to induce high levels of UDS, but as a range of doses was tested 50 cells from each of two slides per animal were scored to facilitate the detection of potentially weak responses at the low dose. The vehicle (negative control) for each compound was administered by multiple dosing only, on the assumption that no difference in results should be expected whichever protocol was used.
Comparison of multiple and single dosing were performed in experiments carried out on two separate occasions for DMH and 2-AAF and on one occasion for DMN.
Hepatocyte isolation and radiolabelling
A method incorporating minor modifications to the protocol of Butterworth et al. (1987) was followed. Hence, Williams' incomplete (WEI) and complete fWEC) media, 0.5 mM EGTA [ethylene glycol-bis(pVaminoethyl ether)-AWV',JV-tetraacetic acid], [ 3 H]thymidine (25 Ci/mmol) solution (10 \iC\l ml), unlabelled thymidine solution (0.25 mM) and methyl green pyronin Y solution were prepared as specified. For the collagenase I solution (100 U/ ml) RPMI 1640 medium was used instead of William's medium E. RPMI 1640 also replaced William's medium E in WEC used for the first three of four hepatocyte washes after their isolation.
Each liver was perfused to waste with 0.5 mM EGTA for 3.5 min followed by 100 U/ml collagenase for 12 min (or less, depending on the extent of 'digestion'). It was then removed, cut into small pieces and sieved through a 125 Jim filter to remove clumps and debris. After four washes (centrifugation was at 80 g for 1 min) hepatocytes were assessed for viability using trypan blue and resuspended at 3X10 3 viable cells/ml in WEC (hepatocyte preparations with cell viabilities of <50% were rejected and usually attributable to technical difficulties encountered during the perfusion). Aliquots of 3 ml of this suspension were added to each well of a 6-well-cluster tissue culture plate (Costar) which contained plastic 25 mm diameter Thermanox® coverslips (Nunc Inc.). Cultures were then incubated for 2 h in a humidified 5% CO2 incubator at 37°C to allow hepatocyte attachment to the coverslips, after which the culture medium was replaced once with WEI to remove unattached cells and cultures were further incubated for 4 h with [ 3 H]thymidine solution. After radiolabelling excess unbound [ 3 H]thymidine was removed from the cultures using a 'cold chase' procedure whereby [ 3 H]thymidine solution was replaced with four changes of unlabelled thymidine solution followed by overnight (12-14 h) incubation with the latter. Cultures were then washed once with WEI prior to fixing. Fixatives were compared using additional, non-radiolabelled cultures from negative control animals. All three fixatives were tested with cells of each culture so that direct comparisons could be made.
Autoradiography
Coverslips were attached to slides and coated in emulsion (Ilford K2 diluted 1:1 with water) containing 2% (v/v) glycerol at 43°C by dipping. They were dried in a dark, sealed drawer for 4 h and then placed in light-proof slide boxes containing silica gel for 7 days at 4°C. Slides were developed by immersion for 5 min in Phenisol (Ilford) diluted 1:4 with water, rinsed for 1 min with water and then fixed for 5 min in Hypam (Ilford) diluted 1:4 with water. Development, rinsing and fixing stages were performed at 18°C and purified water was used throughout After fixation the slides were rinsed in running tap water for 10 min and then stained immediately. Several variations in fixing and staining were tried (see Results).
Slide scoring
Scoring was facilitated by image analysis. Grain measurements were by area and grain 'counts' were derived by dividing these area measurements by the mean area of a single grain, the latter being derived by measuring single grains (> 100) of a negative control slide from the same experiment For each cell we measured the number of grains over the nucleus (N) and those over an equal area of cytoplasm (C). The area of cytoplasm was chosen without intentional bias towards parts with high or low numbers of grains; the only selective criterion being an area of cytoplasm sufficiently large to accommodate the frame (counting area) of the image analyser. Nett nuclear grain (NNG) count was derived by subtracting C from N. As side issues we investigated the effect of selecting the area of cytoplasm with the highest density of grains versus our normal (random) selection of area for counting and undertook a comparison of our normal automated counting technique with manual counting.
Statistical analysis
Where results are either clearly negative or clearly positive statistical analysis is not usually performed. In other circumstances, where statistical analysis is deemed necessary, data are first transformed using a non-parametric rank transformation, i.e. NNG scores for each animal from treated and negative control groups are arranged in ascending order and each assigned a rank number (1 to n) (Iman, 1974; Conover and Iman, 1981) . Parametric analysis of the rank numbers is then performed using Dunnett's test (Dunnett, 1955; Bechhofer and Dunnett, 1988; Mahon et aL, 1989; Mitchell et al., 1994) . Compound 'X', a pharmaceutical undergoing evaluation within the Unit, is used to demonstrate our statistical methodology, which is set out in Table Va -c. A t value is then calculated for each treatment group, as described in footnote a to Table V, and is assessed for significance by comparison with critical values derived from tables in Bechhofer and Dunnett (1988) .
Results
Technical investigation of autoradiography, fixing, staining and grain counting
The 7 day exposure period used for these studies gives reduced background grain counts compared with those observed with the 14 day exposure period used when we first tried the assay. Quantitative analysis to substantiate this was not deemed necessary, because the difference was apparent to the naked eye. However, intra-assay inconsistencies in background were still apparent; notably that it was higher and more unevenly distributed on positive control slides. A probable reason for this finding was that the nuclei of many of the S phase cells were disrupted by fixing with 25% acetic acid/ethanol, resulting in much of their highly radiolabelled contents being shed across a wide surrounding area. This was particularly apparent with hepatocytes derived from animals treated with 2-AAF. Furthermore, since the cytoplasm of many of the cells from both positive and negative controls was severely disrupted and appeared condensed or even absent on occasions, the use of different fixatives was investigated and the subsequent findings are given below.
Photographs of hepatocytes from cultures derived from the same animal fixed using the three fixing regimes are shown in Figure la-c. Fixing with the recommended 25% acetic acid/ ethanol often caused cytoplasmic disruption and loss (worst case Figure la ), making it difficult to find cells of 'normal' morphology, a pre-requisite for scoring. Additionally, and probably as a result of the poor fixation, the staining was very inconsistent, even on the same coverslip, and resulted in many intensely stained areas, which are a problem when using image analysis as they may be counted as grains. Fixation with 3% acetic acid/ethanol or 4% PFA was equally more effective than 25% acetic acid/ethanol in maintaining cytoplasmic morphology without disturbing that of the nuclei and, therefore, in subsequent experiments cell staining was more consistent and autoradiographic background counts were markedly reduced.
Methyl green pyronin Y stain on occasion caused intense staining of the nucleoli which interfered with automated grain counting. When cells were stained with 0.5% eosin ( Figure  Id) , primarily a cytoplasmic stain, the nuclei and nucleoli remained pale, although easily distinguishable against a pink cytoplasm. This enables autoradiographic grains to be detected more effectively, since the threshold for the grain detection range can be lowered without interference from intense staining of other cell constituents.
Investigation into the effect of counting cytoplasmic grains in areas selected for high grain counts showed that this gave an increase in cytoplasmic grain counts of -35% over counts derived from randomly selected areas. This figure was remarkably constant, irrespective of whether grain counts were generally high or low in the assay being investigated. In a direct comparison counting grains manually yielded figures -1.4-fold less than those obtained by image analysis.
Hepatocyte viability, UDS response and cell attachment
Cell viabilities (%) for all animals are shown in Tables I and  II. Statistical analysis of our results shows that there is no correlation (P > 0.05) between cell viability and NNG either for negative control animals or those dosed with either DMH, DMN or 2-AAF. The absence of any correlation is also demonstrated graphically in Figure 2 , which also contains some additional data from in-house studies.
Hepatocytes prepared from one of the animals that had been multiple-dosed with DMH (Assay 1) and from one negative control animal (Assay 2) were rejected as their cell viability fell below 50%. These low viabilities resulted from technical problems encountered during the perfusions. In both assays reduced cell attachment was observed in cultures derived from animals that had received two doses of DMH and probably resulted from cumulative toxicity. It is important to note that the reductions in cell attachment did not correlate with reduced cell viabilities, which are given in Table I . Cell attachment is probably a more reliable and sensitive measure of cell viability than the trypan blue method.
Multiple versus single dosing
Grain counts and cell viability measurements for individual animals are given in Tables I and II and group data in Table  III . Data from Tables I and II indicate that inter-animal variation is not excessive. For DMH, DMN and 2-AAF mean NNG values observed with multiple dosing were not statistically different (P > 0.05 using Student's /-test on ranktransformed data) from those observed with the single-dose protocol. NNG values for 2-AAF and DMH were marginally higher for multiple dosing, whilst those for DMN were slightly higher in the single-dose experiment. Although results are not tabulated, it should be noted that in Assay 1 DMH gave a similar mean NNG (6.8) when sampled sub-optimally at 12-16 h compared with the value of 8.3 that was obtained when sampled at its optimal time point. 2-AAF when sampled suboptimally at 2-4 h gave a mean NNG (9.2) about half that obtained when sampled at its optimal time point (17.6).
The range of doses of DMN tested (2.5, 5.0, 10.0 mg/kg) by multiple dosing demonstrated the expected increase in NNG with increasing dose. However, in rats given a single dose of DMN at 10.0 mg/kg an almost 2-fold increase in NNG was observed over that obtained from rats dosed twice at 5.0 mg/ kg, thus demonstrating the absence of a cumulative effect for this compound. •Low viability resulted from technical problems, hence cultures were rejected. 1 %MC, 1 % (aqueous) methylcellulose; N, nuclear grain count; C, cytoplasmic grain count; NNG, nett nuclear grain count; Per cent IR, percentage of cells in repair (i.e. with NNG * +5).
Historical database for negative controls
Our historical database is derived from group means and is shown in Table IV . Maximum, minimum, mean and median values are given for nuclear, cytoplasmic and NNG counts, together with 95 and 99% confidence limits. It should be noted that positive values for negative control NNG count fall within the 95% confidence limits and were, in fact, occasionally observed for individual animals. These confidence limits are generated by assuming a normal distribution of group means. Such an assumption is based on the central limit theorem, whereby means tend to normality even when the individual data are non-normal, and is also supported by data from Margolin and Risko (1988) . It should be noted that while the inter-test variability of grain counts is quite high, the intra-test variability is reasonably low (Tables I and II) .
Statistical analysis
Results for DMH, DMN and 2-AAF were clearly positive and there was no requirement for statistical analysis. However, for the purpose of demonstrating the use of Dunnett's test with rank-transformed data (Mitchell et al., 1994) results for compound 'X' and their analysis are given in Tables Va-c.
Discussion
Technical improvements
The reduction in autoradiographic background observed when the exposure time was reduced from 14 to 7 days is consistent with the findings of Hamilton and Mirsalis (1987) and Butterworth et al. (198.7) . A 7 day exposure time has now been adopted in this laboratory, but the optimal exposure time may vary according to the specific activity of the [ 3 H]thymidine used. UKEMS guidelines (Kennelly et al., 1993) for the in vivo/ in vitro rat hepatocyte UDS assay suggest that only cells of 'normal' morphology should be scored. Cell morphology is dependant on the method of fixation and 25% acetic acid/ ethanol, the recommended fixative for this assay, often caused severe cytoplasmic disruption and contraction. This disruption may lead directly or indirectly to physical damage to the nucleus, resulting in the release of relatively large amounts of radiolabelled DNA, particularly from S phase nuclei. This DNA becomes fixed to the surface of the coverslip and other cells, thus elevating the background count, which in turn reduces the sensitivity of the assay (Hamilton and Mirsalis, 1987) . Furthermore, as the qualitative evaluation of UDS assays depends on quantitative counting of equivalent areas over the nucleus and cytoplasm, if the cytoplasm appears contracted the cytoplasmic count will be artificially high, resulting in an artificially low NNG count. We have shown that 3% acetic acid/ethanol gave better cytoplasmic and nuclear fixation than 25% acetic acid/ethanol, a finding in accordance with that of Bourne (1990) , who recommended it for fixing thin cytological preparations such as smears. It is likely that acetic acid, which is primarily used to enhance nuclear fixation (Bourne, 1990) , is disruptive to cytoplasm when used at concentrations as high as 25%. Fixation using 4% PFA was at least as good as 3% acetic acid/ethanol, however, we currently prefer the latter for its ease of preparation.
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Recommended stains, such as methyl green pyronin Y and haematoxylin/eosin, can cause intense staining, particularly of nucleoli, which can interfere with grain counting when using automated techniques. Such stains may not be appropriate when grains are to be counted by image analysis, especially where there is no necessity for fine morphological detail and the only requirement is for staining to be of sufficient intensity to produce adequate contrast between nucleus and cytoplasm. The use of 0.5% eosin on its own appears to achieve this objective very well.
Hepatocyte viability and UDS response
Our observation that cell attachment rather than viability seems a better indicator of assay function, which is supported by the findings of Ashby et al. (1985) , has caused us to add an extra animal per group in the range-finding test (Mackay and Elliott, 1992) to enable cell attachment to be assessed. Our data also agree with those of Ashby et al. (1985) and Fautz et al. (1993) in that the UDS response is unrelated to cell viability ( Figure  2) as assessed by trypan blue. It is axiomatic that without cell attachment there is no possibility of measuring UDS and this is relevant in the case of DMH, where multiple dosing caused a decrease in cell attachment (unrelated to cell viability). Consequently, there seems no point in rejecting animals from data analysis unless cell viability falls below 50% (or perhaps even less).
Grain counts for negative controls
Generally our negative control grain counts in all assays (Tables I-IV) are higher than the average cited in the literature (Kennelly et al., 1993) . The reason is likely to be technical. A possibility (suggested by one referee) is that the change in our fixation technique (using more dilute acetic acid) may prevent acid-soluble, unincorporated radiolabel being washed out. Alternatively, it may be related to the set-up of our automated image analyser, where low intensity staining, using 1%MC, \% (aqueous) methylcellulose; N, nuclear grain count; C, cytoplasmic grain count; NNG, nett nuclear grain count; Per cent IR, percentage of cells in repair (i.e. with NNG * +5). eosin alone, allows us to reduce the threshold for grain detection. We also note that in comparative studies manual counts yielded lower values than image analysis (by ~ 1.4-fold); this is probably due to the inability of the eye to accurately quantitate grains when they occur in clusters. In terms of assay function this is not a serious issue, as all data are relative and the key measurement is NNG count, found by subtracting cytoplasmic grains (C) from nuclear grains (N).
Our NNG counts (group means) vary from 0.0 to -6.4, with a mean of -2.2, 95% confidence limits of -7.9 to +3.5 and with individual animals showing positive NNG counts on occasion. These values are higher than those given in the literature for reasons likely to be related to gTain counting methodology. Butterworth et al. (1987) suggest that the mean NNG of the negative controls should be ^0 and Kennelly (1995) states values for individual animals should not exceed 0. However, when calculating the NNG for each cell these authors recommend that the area of cytoplasm with the highest grain density should be used. Conversely, in this laboratory -7.7 to 27.3 -11.9 to 37.1 -10.4 to 5.0 N, nuclear grain count; C, cytoplasmic grain count; NNG, nett nuclear grain count Table Va . Nett nuclear grain count data for compound Treatment NNG 0 g/kg (negative control) -1.6, -1.7, -1.7, -1.2, -1 4 g/kg compound 'X' -2.7, -3.7 2 g/kg compound 'X' -0.4, -0.5, -1.8, -3.5 NB: two animals were lost from the 4 g/kg group. -3.7 -3.5 -2.7 -1.9 -1.8 -1.7 -1.7 -1. we select the cytoplasmic area to be analysed without such intentional bias; we found that selection of areas with the highest grain density resulted in an increase in cytoplasmic grain count of 35%. It follows, therefore, that NNG values generated using our methods will tend to be higher than those obtained by the aforementioned authors, a finding supported by in vitro work of Brambilla and Martelli (1992) giving NNG values for negative controls in the range -1.3 to +2.7. Furthermore, minimization of cytoplasmic disruption and contraction by our fixing method may lower grain counts per unit area and hence give higher NNG values. Taking these factors into consideration, our historical mean NNG count and 95% confidence limits are in reasonable agreement with data from other laboratories (Butterworth et al., 1987; Kennelly et al., 1993; Kennelly, 1995) . It follows that with our methodology occasional (rare) positive values for mean negative control NNG are to be expected and assays with a NNG > 0 for the negative control group should not be rejected. Such control data should be included in the historical database, otherwise this will be distorted, biased and therefore useless.
In terms of assay validity the good intra-assay reproducibility (Tables I and II) is reassuring. Without this, the inter-test variability, which is generally greater than that cited in the literature (Kennelly et al., 1993) , might be grounds for concern. .The reason that our inter-assay data are more variable may be the result either of some technical variation in our laboratory or simply of the relatively small data set (eight assays). However, we think the answer may be that some laboratories reject assays in which more extreme values are observed. Such a practice will inevitably result in 'apparent' low variability. It is important that extreme values are always included in historical databases unless there are technical/experimental reasons for exclusion. If this is not done, a biased (falsely low) value for test variability will result.
Data from agent treatments
Our results show that both the two-dose/single-sample and single-dose/two-sample regimes give very similar responses with all three standard positive control agents, DMH, DMN and 2-AAF. Therefore, in terms of positive control function both assays are acceptable alternatives. It was slightly surprising that DMH and 2-AAF did not give considerably larger responses (cumulative) when dosed twice, in view of their effectiveness at their sub-optimal as well as their optimal sampling time (see Results). We speculate that at the doses used a near maximum (plateau) response may have been reached for each compound, so that a cumulative effect could not be reflected in the response. Results with DMN enabled a slightly more detailed comparison of the multiple and single "The / value for our results is derived from the following two equations: (i) S = <(AIB) (ii) t = (X l where X t = treatment mean, X c =-control mean, n, = number of animals in treatment group, n,. = number of animals in control group. ""Critical values for t derived from Bechhofer and Dunnett (1988) .
Two-dose/single-sample in vivolin vitro rUDS assay
dosing schedules and demonstrated that two doses of 5 mg/kg gave a lower response than the single dose of 10 mg/kg, again suggesting that the responses to each dose were not cumulative. Such a finding is not unexpected, because DMN is known to be absorbed rapidly, thereby leading to maximal responses at the 2-4 h sampling time and lower responses at the 12-16 h sampling time (Kennelly et al, 1993) . A further consideration is that DMN is a DNA methylating agent and it is possible that it may induce tolerance to methylation via loss of mismatch repair (Branch et al, 1995) on the first dose, so that the DNA damage from the second dose (sampled 2-A h post-treatment) might undergo less repair than would have occurred if this had been the first dose.
Unfortunately, our results for DMH, DMN and 2-AAF are of limited help in assessing the benefits of multiple (two) over single dosing, because the key issue of whether the two-dose regime allows a higher total dose was not determined. In general there are two possible extremes when using multiple (two)-dose regimes. In the 'worst case' scenario the genotoxic effect from one of the two doses is ineffective whereas the systemic toxicity is cumulative. This means that when using a two-dose regime less compound can be applied at the effective time point as compared with a single-dose regime, hence, a weak positive may be undetected. Conversely, if the systemic toxicity from two doses shows no cumulative effect but the genotoxicity is cumulative, then the two-dose regime will enable more compound to be used, thereby facilitating the detection of a weak positive that may be missed by a singledose regime. Without a very large database it is impossible to predict which scenario will occur more often. The situation is likely to be very similar to that with micronucleus assays, where single-dose/multiple-sample and multiple-dose/singlesample regimes are both adequate for most compounds, but one or other is superior in a minority of cases (Ashby and Mirkova, 1987; Garriott et al, 1988; Sutou et al, 1990) without any clear indication of overall advantage one way or the other (Mavournin et al, 1990; Richold et al, 1990) . We note that more prolonged multiple dosing has proved effective in detecting UDS in some cases where single-dose regimes have failed (Puri and Muller 1989; Mirsalis et al, 1993) .
In summary, there is no evidence as to whether the twodose regime will detect more or less compounds as positive than the single-dose regime. Indirect evidence from the micronucleus assay suggests that there will be very little difference. However, the two-dose/single-sample regime has clear advantages in that less animals and resources are used in an assay, which also has better statistical discriminatory power (because there is not the problem of multiple comparisons arising from two separate samples).
Analysis of data
The relatively high probability (P > 0.05) of mean negative control values exceeding 0 by our methodology renders the previously used criterion of assay validity (control NNG < 0) inappropriate. We suggest that it is replaced by a requirement that the negative control value falls within or close to the 99% confidence limits set on the laboratory historical data range. Similar requirements should also be placed on nuclear and cytoplasmic grain counts. This does depend on having a reasonably large historical database, probably >8-10 data sets.
As with the criteria for assay validity, we are attempting to avoid the use of arbitrary values such as 'NNG.> 5' and '>20% cells in repair' when setting criteria for positivity. Therefore, in this laboratory a positive result is defined by at least one dose of test agent giving an increase sufficient to make treatment values overall significantly greater than the negative control value (P =s 0.05), provided that this has arisen from an increase in nuclear and not a decrease in cytoplasmic count. Also, a positive response should fall outside the upper 99% confidence limit for NNG of the negative control historical data. Similar criteria are used with other genetic toxicology tests and avoid the use of arbitrary values for determining positive or negative outcomes.
It is not easy to decide on a suitable statistical analysis, because distributions generated from biological assays are frequently skewed or of uncertain form. The latter is the case with the in vivo UDS assay, where NNG counts seem to show a negative skew (Kennelly, 1995) and this contra-indicates the use of normal distribution statistics. Furthermore, oudiers are frequently observed in biological data and will excessively bias the outcome of the analyses. The solution to this problem is to use non-parametric analyses, which allow for genuine inter-animal differences; i.e. non-uniformity of sampling circumstance (Campbell, 1974) . However, such analyses based on ranks, normal scores or maximum deviations (Bradley, 1968a,b,c) often lack the power and/or versatility of parametric analyses. An interesting solution to this dilemma is parametric analyses of ranks, which combines the power and versatility of parametric analyses with the generality of a non-parametric methodology (Iman, 1974; Iman and Conover, 1979; Conover and Iman, 1981, 1982) and works in practice with equivocal data from mouse lymphoma TK +/~ assays (Mitchell et al, 1994) , where sample replication is less (duplicates) than in the UDS assay (triplicates or quadruplicates).
We therefore recommend analysis of in vivo UDS data by rank transformation followed by the use of Dunnett's test (Dunnett, 1955; Bechhofer and Dunnett, 1988) , as this is designed to allow comparison of several samples with the control without the assumption of a monotonic increase with dose. Although the latter is the usual type of response with genotoxicity data, it is not universal and there are occasions where the highest dose does not give the greatest response (Mitchell, 1987) . We therefore prefer Dunnett's test to the more restrictive analyses where responses are assumed to be monotonic, such as the Williams' test (Williams, 1972) . It should be noted that our usual test design of six animals in the negative control group with four in each of two test groups (scoring 75 cells from each of two slides per animal) gives near optimal statistical power for a test of this size (Dunnett, 1955) . However, the use of other designs, even those using smaller group sizes, as demonstrated with our example (Table Va-c), is not precluded.
Conclusion
We conclude that dosing twice in the in vivo/in vitro rat hepatocyte UDS assay is an acceptable alternative to the widely used single-dose/two-sample protocol. We consider it worthwhile to conduct a range-finding test to prepare hepatocyte cultures, so that cell viability and, more importantly, cell attachment can be assessed for use in the selection of doses for the UDS assay. However, current evidence suggests that there is no necessity to set acceptable levels of cell viability >50%. Statistical techniques based on historical and concurrent data can be applied to assessment of both the validity and outcome of assays and are preferable to the use of arbitrary criteria.
